MEI 001
Alternative Names: MEI-001Latest Information Update: 10 Jul 2025
At a glance
- Originator Nanjing Minova Pharmaceutical
- Class Skin disorder therapies
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
No
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preclinical Skin aging